View Clinical Trial (Medical Research Study)


Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of Diverticulitis - NCT01038739-32168(Clinical Trial 616812)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup

City:  New Smyrna Beach
State:  
FL
Zip Code: 32168
Conditions: Diverticulitis
Purpose: The purpose of the study is to determine which dose of mesalazine granules compared to placebo is more effective in the prevention of recurrence of disease.
Study summary: The primary purpose of the study is to demonstrate the superiority of mesalazine granules compared to placebo in terms of the two primary efficacy variables 'proportion of recurrence-free patients within 48 weeks' and 'proportion of recurrence-free patients within 96 weeks'.
Criteria: Inclusion Criteria: - Diagnosis of left-sided uncomplicated diverticular disease confirmed by computed tomography - Presence of at least one diverticulum of the left colon - Most recent attack of left-sided uncomplicated diverticulitis responding to antibiotics and/or dietary modification within the last 6 months - C-reactive protein (CRP) > upper limit of normal (ULN) or leucocytosis at the start of the most recent attack Exclusion Criteria: - Complicated diverticular disease - Right-sided diverticulitis - Previous colonic surgery - Presence of symptomatic organic disease of the gastrointestinal tract - Active colorectal cancer or a history of colorectal cancer - Hemorrhagic diathesis - Active peptic ulcer disease, local intestinal infection - Asthma if careful medical monitoring is not ensured - Abnormal hepatic function or liver cirrhosis - Abnormal renal function
Study is available at: United Medical Research
New Smyrna Beach, FL 32168
United States

Primary Contact:
Ralf Mohrbacher, MSc
Email: mohrbacher@drfalkpharma.de
Phone: +49-761-1514
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.

Data Source: ClinicalTrials.gov
Date Processed: March 23, 2011
Modifications to
this listing:
Only selected fields are shown, please use the link above to view all information about this clinical trial.